Gastroenterology
Volume 136, Issue 1 , Pages 9-16, January 2009

The Accelerating Pace of HCV Research: A Summary of the 15th International Symposium on Hepatitis C Virus and Related Viruses

  • Robert E. Lanford

      Affiliations

    • Southwest Foundation for Biomedical Research, San Antonio, Texas
    • ,
  • Matthew J. Evans

      Affiliations

    • Department of Microbiology, Mount Sinai School of Medicine, New York, New York
    • ,
  • Volker Lohmann

      Affiliations

    • Department of Molecular Virology, University of Heidelberg, Heidelberg, Germany
    • ,
  • Brett Lindenbach

      Affiliations

    • Section of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut
    • ,
  • Michael Gale Jr

      Affiliations

    • Department of Immunology, University of Washington, Seattle, Washington
    • ,
  • Barbara Rehermann

      Affiliations

    • Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland
    • ,
  • Kyong–Mi Chang

      Affiliations

    • University of Pennsylvania and Philadelphia VA Medical Center, Philadelphia, Pennsylvania
    • ,
  • Stanley M. Lemon

      Affiliations

    • Institute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, Texas
    • Corresponding Author InformationAddress requests for reprints to: Stanley M. Lemon, MD, Institute of Human Infections & Immunity, 6.200 Galveston National Laboratory, University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555-0610. fax: (409) 747-6514

published online 20 November 2008.

Abbreviations used in this paper: CLDN1, claudin-1, HCVcc, cell culture-infectious virus, HCVpp, hepatitis C virus–pseudotyped viral particles, IFN, interferon, ISG, interferon-stimulated gene, OCLN, occludin, PD-1, programmed death-1, TLR, Toll-like receptor

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors disclose the following: Supported in part by National Institute of Allergy and Infectious Diseases grants U19-AI040035 (to S.M.L., R.E.L., M.G.), R01-AI060389 (to M.G.), NIKKD, NIH intramural research program (BR) R01-AI47519 (to K.-M.C.), and K99-AI077800 (to M.J.E.), National Cancer Institute grant K01-CA107092 (to B.L.), and Deutsche Forschungsgemeinschaft grant Lo 1556/1-1 (to V.L.).

 S.M.L. serves as a consultant to Genelabs Technologies, Abbott Laboratories, GlaxoSmithKline, and Pfizer, and R.E.L. is a consultant for Abbott Laboratories. The remaining authors disclose no conflicts of interest.

PII: S0016-5085(08)02048-9

doi:10.1053/j.gastro.2008.11.019

Gastroenterology
Volume 136, Issue 1 , Pages 9-16, January 2009

Article Tools

* Image Usage & Resolution